NexgenRx Inc. (NXG.V)
| Previous Close | 0.2200 |
| Open | 0.2200 |
| Bid | 0.2200 x 0 |
| Ask | 0.2400 x 0 |
| Day's Range | 0.2200 - 0.2200 |
| 52 Week Range | 0.1800 - 0.3300 |
| Volume | |
| Avg. Volume | 10,125 |
| Market Cap | 15.517M |
| Beta (5Y Monthly) | 0.23 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0000 |
| Earnings Date | May 06, 2024 - May 10, 2024 |
| Forward Dividend & Yield | 0.01 (4.55%) |
| Ex-Dividend Date | Dec 28, 2023 |
| 1y Target Est | 4.25 |
ACCESSWIRENexgenRx Announces 2023 Year End Results With Solid Revenue Growth, Continuing Positive EBITDA
TORONTO, ON / ACCESSWIRE / April 5, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its annual financial results for the financial year ended December 31, 2023, with continued revenue growth to $3,573,751 for the quarter ...
- ACCESSWIRE
NexgenRx Announces Share Issuances Under Consulting Agreement
TORONTO, ON / ACCESSWIRE / March 12, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce the issuance of an aggregate of 390,625 common shares at a price of $0.32 in respect of the second and third quarterly equity payments under ...
- ACCESSWIRE
NexgenRx Announces Director Resignation
TORONTO, ON / ACCESSWIRE / December 29, 2023 / NEXGENRX INC. ("NexgenRx" or the "Company") announces the retirement of Dave Bennett from its Board of Directors as he has accepted a senior executive role in the industry and as such will be devoting ...
